Evidence map›Paper›PMID 31523331›Full record

ArticleGastroenterology research2019

Chronic Pancreatitis Leading to Pancreatogenic Diabetes Presenting in Diabetic Ketoacidosis: A Rare Entity.

Gabriel Melki, Linda Laham, Gres Karim, Fnu Komal, Vinod Kumar, Shaker Barham, Matthew Grossman, Sugabramya Kuru, Hadir Mohamed, Rana Garris and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Gastroenterology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Gabriel MelkiDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Linda LahamDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Gres KarimDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Fnu KomalDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Vinod KumarDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Shaker BarhamDepartment of Gastroenterology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Matthew GrossmanDepartment of Gastroenterology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Sugabramya KuruDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Hadir MohamedDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Rana GarrisDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Walid BaddouraDepartment of Gastroenterology, St. Joseph's University Medical Center, Paterson, NJ, USA.
St. Joseph’s University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus type 3c (DM3c) is an uncommon cause of diabetes due to pancreatic pathology. Its prevalence reaches about 5-10% among all diabetics in the Western world, largely due to chronic pancreatitis. DM3c occurs due to the destruction of the endocrine islet cells. Glucagon and insulin levels are both decreased due to the destruction of alpha and beta cells, respectively. This makes the development of diabetic ketoacidosis (DKA) a rare process in patients with DM3c because of the destruction of glucagon, which facilitates ketone production. We report a case of DM3c presenting with DKA. The patient presented with a history of chronic pancreatitis and was on pancreatic enzyme replacement therapy. Prior records revealed that HbA1c levels were normal. Prior computed tomography evidence revealed diffuse pancreatic calcifications. The patient was admitted for DKA, presenting with hyperglycemia, blood glucose of 703 mg/dL, bicarbonate of 16 mmol/L, ketones in the urine and acetone in the blood. The patient's anion gap corrected for albumin was 27. The patient was admitted to the medical intensive care unit where he was treated with intravenous (IV) insulin and IV hydration. Once the anion gap closed, the patient was transitioned to long-acting insulin. HbA1c level on admission was elevated, autoimmune causes of diabetes were sent and were negative, ruling out late onset type 1 diabetes. This shows that although it is a rare phenomenon, diabetics with DM3c can present in DKA.

Indexed as

Chronic pancreatitisDiabetes mellitus type 3cDiabetic ketoacidosisPancreatogenic diabetes

Identifiers

PMID31523331
PMCPMC6731042
OpenAlexW2969836713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.